Zobrazeno 1 - 10
of 11
pro vyhledávání: '"D R Vlock"'
Autor:
J M, Kirkwood, R A, Mascari, H D, Edington, M S, Rabkin, R S, Day, T L, Whiteside, D R, Vlock, J M, Shipe-Spotloe
Publikováno v:
Cancer. 88(12)
Antitumor effects of antibodies against ganglioside antigens of melanoma have been reported, but neither optimal doses nor mechanisms have been established.This Phase IB trial of the murine immunoglobulin IgG(3) monoclonal antibody R(24) against disi
Autor:
M J, Chang, W D, Yu, L M, Reyno, R A, Modzelewski, M J, Egorin, K, Erkmen, D R, Vlock, P, Furmanski, C S, Johnson
Publikováno v:
Cancer research. 54(20)
We have previously demonstrated that the cytokine interleukin 1 alpha (IL-1 alpha) significantly potentiates the antitumor activity of a variety of chemotherapeutic agents, including cisplatin (cDDP). In studies described here, we examined the potent
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 11(12)
PURPOSE To evaluate the correlation between the presence and titer of host-derived antibody reactivity, circulating immune complexes, and clinical course and prognosis in patients with squamous cell carcinoma of the head and neck (SCCHN). MATERIALS A
Autor:
John M. Kirkwood, H. Jones, E. A. Saria, R. Schwartz, Marc S. Ernstoff, D. R. Vlock, N. Wedel, K. Selvaggi, S. Ackerman
Publikováno v:
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy. 13(3)
XOMAZYME-Mel (XMMME-001-RTA) is an immunoconjugate comprised of ricin A chain conjugated to a murine monoclonal antibody directed against high molecular weight melanoma antigens. Although not necessarily related to increased toxicity or decreased eff
Autor:
D R, Vlock
Publikováno v:
Hematology/oncology clinics of North America. 5(4)
The role of the immune system in the pathogenesis and treatment of cancer remains to be determined. Impairment of humoral and cellular immunity has been associated with various factors implicated in head and neck cancer--tobacco, alcohol, and malnutr
Autor:
D R, Vlock
Publikováno v:
Immunology series. 53
Autor:
J M Kirkwood, D R Vlock
Publikováno v:
Journal of Clinical Investigation. 76:849-854
The low titer and incidence of autologous antibody to melanoma has hampered its evaluation. Through acid dissociation and ultrafiltration of serum, we have been able to augment the autologous immune response in 9 of 10 patients studied. This result s
Publikováno v:
Cancer. 49(11)
Malignant melanoma is considered unresponsive to conventional radiation therapy when it is delivered at a daily dose rate of 130--300 rad/fraction. Previous studies have suggested that this is in part due to a large shoulder on the radiation survival
Autor:
J M, Kirkwood, D R, Vlock
Publikováno v:
Cancer research. 44(9)
Sera of 22 individuals were examined for immunoglobulin M (IgM) and immunoglobulin G (IgG) antibody to autologous cultured tumor cells. Reactive native IgM was detected by immune adherence in four, and IgG by Protein A hemadsorption in five, sera. Di
Publikováno v:
Cancer research. 49(6)
Serum antibody reactivity to squamous cell carcinoma of the head and neck (SCCHN) was evaluated in 41 autologous serum-tumor cell line combinations using the protein A hemadsorption assay. Autologous antibody reactivity (median titer of 1:4) was dete